Please provide your email address to receive an email when new articles are posted on . KOLOA, Hawaii — Having a standard method of communication in place for staff helps prevent wrong intravitreous ...
Repeated intravitreal injections of the vascular endothelial growth factor (VEGF) inhibitor bevacizumab (Avastin) may increase the risk of uncontrolled glaucoma, according to a Canadian study in JAMA ...
Patients with age-related macular degeneration who received seven or more eye injections of the drug bevacizumab annually had a higher risk of having glaucoma surgery, according to a study. Patients ...
The purpose of this study was to conduct a questionnaire-based survey of subjective visual perceptions induced by intravitreous (IVT) injections of therapeutic agents. Patients undergoing an IVT ...
Among patients with proliferative diabetic retinopathy, treatment with an injection in the eye of the drug ranibizumab resulted in visual acuity that was not worse than panretinal photocoagulation at ...
Please provide your email address to receive an email when new articles are posted on . Selectively inhibiting the vascular endothelial growth factor (VEGF) has proven to be an efficacious treatment ...
We previously designed a modified channelrhodopsin-1 (mVChR1) protein chimera with a broader action than that of Chlamydomonas channelrhodopsin-2 and reported that its transduction into retinal ...
STOCKHOLM, Sweden — Adding fenofibrate to a statin was associated with an 11% lower risk of diabetic retinopathy progression in patients with type 2 diabetes, new study data show. The drug combination ...
A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The drug also showed potential efficacy in patients who failed to optimally ...
Rockville, MD – Researchers are investigating microneedles, nanoparticles and polymer carriers as potential new techniques to combat the leading cause of visual impairment and blindness in the United ...
A study on lampalizumab injections for patients with geographic atrophy found the drug to be associated with a low risk for persistent alterations in intraocular pressure over a year. Researchers ...
Patients with age-related macular degeneration who received seven or more eye injections of the drug bevacizumab annually had a higher risk of having glaucoma surgery, according to a study published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results